LYNDSI ZAPP: Open Payments
NPI 1780054619 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 26 payments from 14 companies in 2025. Trend: 2023 $217 · 2024 $302 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $122 |
| Novo Nordisk Inc | 4 | $68 |
| Lilly USA, LLC | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Amgen Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: UBRELVY, MOUNJARO, JARDIANCE, Rybelsus, SHINGRIX, Wegovy, AIRSUPRA, EVENITY.
Industry payments across ID — which companies pay providers there.
